Treatment of a Cardiac Patient in the Acute Care Setting BY: KATIE - - PowerPoint PPT Presentation

treatment of a cardiac patient in the acute care setting
SMART_READER_LITE
LIVE PREVIEW

Treatment of a Cardiac Patient in the Acute Care Setting BY: KATIE - - PowerPoint PPT Presentation

Treatment of a Cardiac Patient in the Acute Care Setting BY: KATIE OWENS/LEWIS Patient Information o 84 y/o male o PMHx: o Coronary Artery Disease (CAD) o Hypertension (HTN) o Hyperlipidemia (HLD) o S/p Coronary Artery Bypass Graft (CABG) o


slide-1
SLIDE 1

Treatment of a Cardiac Patient in the Acute Care Setting

BY: KATIE OWENS/LEWIS

slide-2
SLIDE 2

Patient Information

  • 84 y/o male
  • PMHx:
  • Coronary Artery Disease (CAD)
  • Hypertension (HTN)
  • Hyperlipidemia (HLD)
  • S/p Coronary Artery Bypass Graft (CABG)
  • thoracic arch aneurysm
  • thoracoabdominal aneurysm
  • Admitted due to severe chest pain
  • Pt. was diagnosed with a Type B Intramural Hematoma
slide-3
SLIDE 3

What is a Type B Intramural Hematoma?

  • We know for sure:
  • Identified by the occurrence of

bleeding into the intimal wall1

  • Cause of the bleeding is up for debate:
  • Vasa vasorum bleeding into the

aortic media2

  • Presence of an intimal defect

(might be considered a subset of aortic dissection in this case)2

slide-4
SLIDE 4

Medical Management of Intramural Hematoma

Possible Treatments:

  • TEVAR2
  • Open surgical repair2
  • Anti-impulse therapy2
  • No difference in outcome when comparing

surgical treatment and medical treatment of 62 patients with a Type B Intramural Hematoma3

slide-5
SLIDE 5

PT was ordered

  • PT ordered to address R LE weakness…

PMHx: R hip disarticulation per patient was completed approximately 10 years ago

slide-6
SLIDE 6

Evaluation

Subjective:

  • Functional level prior to

hospitalization:

  • Bed mobility: Mod I
  • Transfer to/from w/c: Mod I
  • ADLs: Minimal Assistance
  • Pain
  • 3/10 pain at rest

Family/Home Accommodations:

  • Family:
  • Lives with daughter
  • Daughter works full time
  • Home Accommodations:
  • Ramp to enter home
  • 1st floor bedroom and bathroom
  • Trapeze above bed
  • W/c accessible house
slide-7
SLIDE 7

Evaluation continued…

Objective:

  • AROM:
  • WFL for all extremities
  • Strength:
  • Approximately 3+/5 in L LE
  • Approximately 4/5 in bilateral UEs
  • Bed Mobility (Supine to/from Sit):
  • Moderate Assistance
  • Vital Signs:
  • Resting heart rate 58-60 BPM
  • Respiration rate 18 breaths per minute
  • Blood pressure 110/70
  • SpO2 96%
  • Lines & Leads
  • PIV
  • Arterial line (at the radial artery)
  • Sensation
  • Intact bilateral UEs and LEs
slide-8
SLIDE 8

Evaluation Continued

Home Exercise Program

  • 2 sets of 10 supine straight leg raises
  • 2 sets of 10 supine hip abduction
  • 3 sets of 10 supine ankle pumps
  • 3 sets of 10 seated knee extension
  • 3 sets of 10 supine glute squeezes
slide-9
SLIDE 9

Outcome Measure Utilized

AM-PAC Score on Evaluation

  • Raw score=7
  • 84.99% impaired based on the 5 Item

conversion table

  • Recommended cutoff scores to determine

discharge recommendation: 42.94

  • Post-acute care vs home
  • FIM is an additional outcome measure that

could have been used but it is very time consuming, and likely not practical for the acute care setting.5

slide-10
SLIDE 10

Goals and Recommendations

Goals

  • Mobilize supine to/from sit: Mod I
  • Transfer sit to/form stand: Mod I
  • Perform a low pivot transfer to/from bed to w/c: Mod I

Recommendations

  • Discharge to a skilled nursing facility based on

this patient’s AM-PAC score and lack of 24/7 care at home

slide-11
SLIDE 11

Treatment

Vital Signs

  • Heart rate 64 beats per

minute

  • Respiratory rate 18 breaths

per minute

  • Blood pressure 108/68

Mobility

  • Supine to/from sit: Minimal

Assistance

  • Sit to/from stand: Moderate

Assistance

  • Completed 3 sit to/from stands
  • Low pivot transfer from bed to

chair: Moderate Assistance AMPAC

  • Raw score: 11
  • Percent impaired: 60.88%

impaired

slide-12
SLIDE 12

Updated Goals and Recommendations

Goals

  • Mobilize supine to/from sit: Mod I
  • Transfer sit to/form stand: Mod I
  • Perform a low pivot transfer to/from

bed to w/c: Mod I Recommendations

  • Discharge to a skilled nursing facility

despite improvements in this patient’s AM-PAC score due to lack of 24/7 care and inability to perform transfers with modified independence.

slide-13
SLIDE 13

Is Exercise Safe for Patients with Abdominal Aneurysms?6

  • This study explores the safety of exercise for patients with abdominal aortic aneurysms by

monitoring aortic aneurysm enlargement in the presence and absence of 1 year of specified exercise.

  • 57 patients with abdominal aortic aneurysms between the size of 3.0cm-5.0cm were recruited for

this study and the resultant patient population was made up of predominantly white, males who had hypertension.

  • Symptom limited exercise with a target Borg perceived exertion score of 12-14 on a treadmill,

stair climbing, cycling, rowing, and elliptical training 3x/week for 45 min/session + 10 min of resistance exercises

  • Results of this study suggests that exercise has no effect on the diameter of pre-existing

abdominal aneurysms and patients were able to lower their submaximal heart rate significantly

  • ”Exercise-based rehabilitation result in improved risk factor profiles, higher exercise capacity, and

reduced morbidity and mortality.”

slide-14
SLIDE 14

Is Exercise Safe for Patients with Acute Aortic Dissections?7

  • Comparison between early rehabilitation and traditional treatment of Type B Aortic Dissections
  • Traditional treatment- 7 days of bedrest and antihypertensive
  • Rehabilitation treatment- Anti-hypertensives day 1 and began walking short distances day 3 post-
  • nset
  • Resulted in statistically significant decreases in:
  • Delirium
  • Respiratory complications
  • No difference between aortic diameter enlargement and mortality rates
slide-15
SLIDE 15

Prognosis for Individuals with a Type B IMH8

  • 45 patients with a Type B Intramural Hematoma were studied for a time period of 2.7-9.9 years

following initial diagnosis:

  • 40% received no additional treatment during this time period
  • 47% had to undergo TEVAR
  • 24% experienced progression to a Type B Aortic dissection
  • 24% experienced dilatation of the Aorta
  • IMH related mortality rates:
  • 30 days-1.6%
  • 6 months-6.3%
  • 1 years-6.3%
  • Greater than 1 year-47.6%
slide-16
SLIDE 16

Questions?

slide-17
SLIDE 17

Bibliography

1. Li L, Jiao Y, Zou J, Zhang X, Yang H, Ma H. Thoracic Endovascular Aortic Repair versus Best Medical Treatment for High-Risk Type B Intramural Hematoma: A Systematic Review of Clinical Studies. Ann Vasc Surg 2018;52:273-279. doi:10.1016/j.avsg.2018.03.010. 2. Tanaka A, Leake S, Estrera AL. Management strategies in acute type B aortic intramural hematoma. Curr Opin Cardiol 2017;32(6):687-691. doi:10.1097/HCO.0000000000000453. 3. Maraj R, Rerkpattanapipat P, Jacobs LE, Makornwattana P, Kotler MN. Meta-analysis of 143 reported cases of aortic intramural hematoma. Am J Cardiol 2000;86(6):664-668. 4. Jette DU, Stilphen M, Ranganathan VK, Passek SD, Frost FS, Jette AM. AM-PAC “6-Clicks” functional assessment scores predict acute care hospital discharge destination. Phys Ther 2014;94(9):1252-1261. doi:10.2522/ptj.20130359. 5. Functional Independence Measure | Shirley Ryan AbilityLab - Formerly RIC. Available at: https://www.sralab.org/rehabilitation-measures/fimr- instrument-fim-fimr-trademark-uniform-data-system-fro-medical. Accessed November 16, 2018. 6. Myers JN, White JJ, Narasimhan B, Dalman RL. Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial. J Cardiopulm Rehabil Prev 2010;30(6):374-383. doi:10.1097/HCR.0b013e3181ebf2db. 7. Niino T, Hata M, Sezai A, et al. Optimal clinical pathway for the patient with type B acute aortic dissection. Circ J 2009;73(2):264-268. 8. Schoenhoff FS, Zanchin C, Czerny M, et al. Aorta Related and All-cause Mortality in Patients with Aortic Intramural Haematoma. Eur J Vasc Endovasc Surg 2017;54(4):447-453. doi:10.1016/j.ejvs.2017.07.001.